Read the latest positive news, breakthroughs, and inspiring stories about vaccine development, curated daily by BrightWire.
Scientists are developing the first-ever vaccine against a deadly parasite that kills cattle within two weeks. The breakthrough could protect America's $100 billion livestock industry from a growing biosecurity threat.
A new public-private partnership modeled after the COVID-19 vaccine effort aims to fast-track personalized cancer vaccines that target tumors in patients who already have the disease. The initiative launches in December and could transform cancer treatment using breakthrough mRNA technology.
A personalized cancer vaccine from Moderna just aced its phase 3 trial for melanoma patients, marking a potential first for mRNA technology in cancer treatment. The same company that brought us a COVID vaccine in record time could soon revolutionize how we fight cancer.
Malaysia has officially joined the International Vaccine Institute to strengthen its vaccine research and development capabilities. The partnership aims to make the nation more self-sufficient in protecting public health through global collaboration.
Eight research teams in Ghana just won €2 million in grants to develop life-saving medicines and vaccines that can be made right at home. The projects range from child-friendly malaria treatments to AI-powered diagnostics, putting Ghana on track to become a pharmaceutical powerhouse for Africa.
Eight Ghanaian research teams just received €2 million to develop medicines, vaccines, and diagnostics right at home. From malaria treatments to snake venom antiserum, these projects will turn laboratory discoveries into products that save lives across West Africa.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
After 40 years of prevention-only treatments, European researchers are developing the first therapies that could free 254 million people from lifelong hepatitis B. Two major clinical trials show new immune-based approaches may finally achieve what vaccines alone couldn't: a functional cure.
A new Ebola vaccine developed in just eight weeks has been given to its first human volunteer, with 600,000 doses already manufactured and ready to deploy. The experimental vaccine targets a deadly Ebola strain currently spreading in the Democratic Republic of Congo.
Researchers working weekends with leftover grant money proved quantum computers can make AI better at designing personalized vaccines. Their breakthrough could help develop drugs that work for understudied populations around the world.
After decades of research, scientists have developed a promising vaccine technology against a dangerous intestinal illness that causes millions of severe cases each year. The breakthrough targets a bacterial infection that disproportionately kills children in developing countries.
Researchers discovered a shared vulnerability in bacteria that kill thousands of children yearly, opening the door to a single vaccine against multiple deadly gut infections. The breakthrough targets how these pathogens break through the gut's natural defenses.